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Background.This study aimed to assess the relationship between illness perception and depressive symptoms among persons with
diabetes. Method. This was an analytical cross-sectional study conducted among 379 type 2 diabetic patients from three major
clinical settings of Kathmandu, Nepal. Results. The prevalence of depressive symptoms was 44.1% (95% CI: 39.1, 49.1). Females
(𝑝 < 0.01), homemakers (𝑝 < 0.01), 61–70 age group (𝑝 = 0.01), those without formal education (𝑝 < 0.01), and people with
lower social status (𝑝 < 0.01) had significantly higher proportion of depressive symptoms than the others. Multivariable analysis
identified age (𝛽 = 0.036, 𝑝 = 0.016), mode of treatment (𝛽 = 0.9, 𝑝 = 0.047), no formal educational level (𝛽 = 1.959, 𝑝 = 0.01),
emotional representation (𝛽 = 0.214, 𝑝 < 0.001), identity (𝛽 = 0.196, 𝑝 < 0.001), illness coherence (𝛽 = −0.109, 𝑝 = 0.007),
and consequences (𝛽 = 0.093, 𝑝 = 0.049) as significant predictors of depressive symptoms. Conclusion. Our study demonstrated
a strong relationship between illness perception and depressive symptoms among diabetic patients. Study finding indicated that
persons living with diabetes in Nepal need comprehensive diabetes education program for changing poor illness perception, which
ultimately helps to prevent development of depressive symptoms.
1. Introduction
Diabetes mellitus is now emerging as a global epidemic. The
problem is growing so rapidly that it is projected to be the
seventh leading cause of death by 2030 [1]. The escalating
burden of diabetes has already surfaced in low and middle
income countries (LMCs) where four out of five people with
diabetes are currently living [2]. Recent population based
studies conducted in Nepal have also reported a growing
prevalence of diabetes among urban, middle, and elderly
population [3–5].
Depression, one of the major comorbid conditions asso-
ciated with chronic diseases [6, 7], has a bidirectional rela-
tionship with diabetes [8, 9]. The presence of depression is
two times more common in people with diabetes than in
those without diabetes [10, 11]. It adversely affects the diet and
treatment adherence, glycemic control, and productivity [12].
Therefore, the coexistence of depression among people with
diabetes worsens the disease outcomes [13].
In diabetic patients, depression has been linked with
the multiple factors like female sex, younger age, not hav-
ing a spouse, poor social support, and low socioeconomic
status, among others [14, 15]. Most importantly, depression
is associated with the perception of patients about their
disease [12, 16]. Illness representation or perception reflects
the patients’ own views about the cause (beliefs about how
the disease occurred), illness identity (beliefs about how
the disease should look like, by relating to the symptoms),
illness consequences (impact of the disease on quality of life,
relationships, and work), timeline (whether the disease is of
long or short duration or has cyclical onset of symptoms),
and cure or control (whether the illness can be controlled
by patient’s behavior or treatment module) [17]. Positive
illness perception is established when the illness is viewed
Hindawi Publishing Corporation
Journal of Diabetes Research
Volume 2015, Article ID 908374, 9 pages
http://dx.doi.org/10.1155/2015/908374
2 Journal of Diabetes Research
as a normal part of life [16, 18]. Curtailed information about
the disease collected from the social interactions, from the
authoritative sources such as doctors, frompatients, and from
his/her own experiences forms an overview regarding the dis-
ease [19]. Such imagemay generate the pessimistic view about
disease that can lead to psychological disorders [18, 20]. On
the contrary, the appropriate knowledge about the condition
may provide healthy judgment regarding behaviors related to
the disease [20]. Literatures have shown relationship between
illness perception and depression in cardiovascular disease
(CVD) and renal diseases [21, 22]. Nepal, however, has dearth
of similar studies in diabetic patients.Therefore, this research
aimed to identify the relationship between illness perception
and depressive symptoms in patient with diabetes.
2. Methods
2.1. Study Setting. Thiswas an analytical cross-sectional study
conducted between December 2013 and June 2014 in clinical
settings in Kathmandu, Nepal. Study sites were Tribhu-
van University Teaching Hospital, Maharajgunj; Diabetes,
Thyroid Care and Endocrinology Center, Kupondole; and
Diabetic Society Clinic, Jamal. Sites were selected purposively
as they were the well-known diabetic treatment centers in
Nepal.
2.2. Participants, Sample Size, and Sampling Method. Study
participants were patients with the diagnosis of type 2
diabetes mellitus attending study sites during the study
period. Sample size was calculated using 𝑍2 ⋅ 𝑝𝑞/𝑑2 formula
[23] at 95% confidence interval and 5% allowable error.
The estimated prevalence of depression among persons with
diabetes was assumed to be 40.3%, based on previous similar
hospital based study [14]. Total sample size came out to be
390.
Samples were proportionately allocated to each study site
with respect to the average number of patient visits to the
centers in previous months. Participants between 20 and 70
years of age attending study sites with present history of
diabetes of at least six months of duration were selected for
the study. The total number of eligible patients registered in
all study sites was 1200. Among them, every third participant
was enrolled in the study.
Patients with diabetic complications like neuropathy,
nephropathy, retinopathy, autonomic neuropathy, and so
forth were excluded because of their independent association
with depression [14]. Likewise, those with the previous
episode of depression or using any antidepressantmedication
were also excluded.
2.3. Ethical Approval. Ethical approval was taken from the
Nepal Health Research Council (NHRC), Ramshah Path,
Kathmandu,Nepal. Each participating institute also reviewed
the study protocol and provided consent for conducting
research. Purpose of the study was clearly explained to all
the respondents. They were well informed about their right
to withdraw from the study at any time. Participants were
also assured that all personal details would be confidential.
Considering no more than minimal risk in research par-
ticipation, verbal consent was taken prior to an interview.
Consent procedure was approved by Ethical Review Board of
the NHRC based on National Ethical Guidelines for Health
Research in Nepal. No financial incentive was provided to the
participants.
2.4. Instruments. The first section of the data collection
tools was structured questionnaires, designed to collect the
sociodemographic data. Age was recorded as the completed
age of participants at the day of interview. Occupations were
recorded in different categories: job (government or non-
government), business, farming, and so forth. Kuppuswamy’s
Scale was used to categorize socioeconomic status of the
participants. It utilizes the level of education, household
income, and occupation for calculating individual’s socioe-
conomic status [24]. Participants were also requested to
report the diabetes duration, use of antidiabetic medications
(insulin/pills) including alcohol consumption, and cigarette
smoking habit.
2.5. Illness Perception Questionnaire-Revised (IPQ-R). The
well validated Illness Perception Questionnaire-Revised
(IPQ-R) was used for assessing the illness perception [25].
The IPQ-R was presented in three sections. Firstly, diabetes
identity was assessed using 14 commonly experienced symp-
toms like headache, joint stiffness, weight loss, and so forth.
For each symptom, participants were asked to indicate (a)
if they had experienced this symptom since their diabetes
and (b) whether they believed the symptom was related to
their diabetes. The responses were recorded as yes/no. The
sum of the yes-rated symptoms on the second scale com-
prises the diabetes identity subscale. Timeline acute/chronic,
timeline cyclical, consequences, personal control, treatment
control, illness coherence, and emotional representations
were assessed in the second section. Altogether 38 items were
presented with a five-point response scale: strongly disagree,
disagree, neither agree nor disagree, agree, and strongly agree.
Lastly, in the third section, 18 possible causes of diabetes were
listed. Responses were recorded on a five-point scale as men-
tioned above. The scale was scored accordingly: strongly dis-
agree = 1, disagree = 2, neither agree nor disagree = 3, agree =
4, and strongly agree = 5. Identity was scored as yes or no,
where yes = 1 and no = 0.
2.6. Beck Depression Inventory-II (BDI-II). BDI-II scale was
administered to assess depressive symptoms among the
participants. It contained 21 questions, each answer being
scored on a scale value of 0 to 3. For clinical interpretation,
presence of depressive symptoms was defined as a BDI-
II score ≥14 [26, 27]. The tool is not validated for use in
Nepal. However, it has been previously used in Nepal for
assessing depression level [28]. We opted to use the tool in
our study, considering its latest improvisation as per DSM-IV
criteria formajor depression [29]. BDI-II omits items relating
to weight loss, body image, hypochondria, and working
difficulty and has added items relating to agitation, worthless-
ness, difficulty concentrating, and energy loss compared to
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earlier versions in order to assess the intensity of depression
[30, 31].
2.7. Translation and Pretesting. The questionnaires were
translated into Nepali by two multilingual researchers indi-
vidually. Translations were compared to identify the dis-
crepancies. Principal investigator mediated the discussion
between two translators and facilitated coming up with single
version. Another bilingual researcher back-translated it into
English and validated it with the original one. Two experts
from Psychology Department of Tribhuvan University con-
solidated the different versions of translations making them
equivalent to source version. Effort was made to ensure that
the translation carried the same meaning as the original
version while also being sensitive to the nuances of Nepali
language. The translated version was pretested among 20
respondents.
2.8. Reliability of the Instruments. For assessing reliability of
both instruments (illness perception, BDI-II), we calculated
reliability coefficients (Cronbach’s alpha) for all nine sub-
scales of illness perception andBDI-II using the study dataset.
2.9. Training. Five research assistants were chosen and
trained to administer the questionnaire in seven- day training
program. They were asked to repeat the mock interviews
under direct supervision of investigators until desired stan-
dards were achieved.
2.10. Data Management and Analysis. Data were compiled,
edited, checked, and validated to maintain consistency. Col-
lected datawere entered in EpidataV.2.1 and exported to SPSS
V.16.0 for further analysis.
Distribution of sociodemographic characteristics by gen-
der was presented in table with frequency and percentage.
Chi-square test was conducted to compare the proportions of
depressive and nondepressive symptoms among respondents
across the sociodemographic strata. Spearman’s correlation
was applied for analyzing the relationship between illness
perception and depression scores. All tests were two-tailed
and 𝑝 < 0.05 was considered statistically significant.
Multivariable analysis was conducted using binary logis-
tic regression. Presence of depressive symptoms was consid-
ered as dependent variable with dichotomous outcomes: 0 =
absent, 1 = present. Those variables that were significantly
associated with depressive symptoms in bivariate analyses
were entered into multivariable model through stepwise
(forward conditional) method. We also conducted stepwise
backward conditionalmethod, where we got exactly the same
result as in forward conditional method. The probabilities
for entry and removal of variable in each step were set as
0.05 and 0.1, respectively. Categorical variables were coded
appropriately before entering them into the model.
3. Result
After excluding 11 participants who did not respond well,
total participants were 379, with 50.1% females and 49.9%
males. The mean age of the respondents was 54.8 ± 10.6
years with median duration of diabetes of 8.7 years (IQR =
10 years). The majority of the participants had age between
51 and 60 years (34.3%), were from nuclear family (85.8%)
and urban area (84.7%), and belonged to Newar ethnic group
(47%) and Hinduism (87.1%). Most of respondents were
homemakers (29.8%) and from lower socioeconomic status
(73.9%) (Table 1).
3.1. Reliability of the Instrument. The reliability of both
instruments was assessed using the study dataset. Reliability
coefficients (Cronbach alpha) were computed for each of
the IPQ-R subscales and the BDI-II score. Among nine
illness perception subscales, six had an adequate reliability
coefficient (𝛼 levels > 0.70). Internal consistency of treatment
control subscale was very low (𝛼 = 0.3). BDI-II scale,
however, showed an excellent reliability with high Cronbach
alpha (𝛼 = 0.869) (Table 2).
3.2. Presence of Depressive Symptoms according to Sociodemo-
graphic Characteristics. The prevalence of depressive symp-
toms among the respondents was 44.1% (95%CI: 39.1, 49.1). It
was significantly high among females compared to their male
counterparts (𝑝 < 0.001). Also, proportions of depressive
symptoms were high among homemakers (65.4%), patients
with lower socioeconomic status (70.9%), and age group 61–
70 years (58.2%) (Table 3).
3.3. Illness Perception. The average score of personal control
was comparatively higher than mean score of other subscales
(Table 3). It is because the majority (75%) of participants
agreed that there was a lot which they could do to control
their symptoms. Most of the respondents (82%) also believed
the course of diabetes depended on them. In contrast to
that, cyclical timeline had the lowest average score among all
subscales. A large proportion of respondents (43%) disagreed
that the symptoms of diabetes changed a great deal from day
to day in cyclical nature.
3.4. Depressive Symptoms and Illness Perception. Spearman
correlation analysis found that identity (𝑟 = 0.525, 𝑝 <
0.001), acute timeline (𝑟 = 0.115, 𝑝 = 0.025) and cyclical
timeline (𝑟 = 0.337, 𝑝 < 0.001), consequences (𝑟 = 0.511,
𝑝 < 0.001), emotional representation (𝑟 = 0.636, 𝑝 <
0.001), and causes (𝑟 = 0.366, 𝑝 < 0.01) components had a
significant positive correlation with BDI-II scores (Table 4).
Contrarily, treatment control (𝑟 = −0.250, 𝑝 < 0.001)
and illness coherence (𝑟 = −0.446, 𝑝 < 0.001) had a
negative relationship with depressive symptoms (Table 4). In
a separate Spearman correlation analysis, duration of diabetes
had no significant relationship with depression scores (𝑟 =
0.013, 𝑝 = 0.802).
In multivariable analysis, all explanatory variables signif-
icant in bivariate analysis were entered by a stepwise (forward
conditional) method into binary logistic regression model.
Seven variables, emotional representation (𝛽 = 0.214, 𝑝 <
0.001), identity (𝛽 = 0.196, 𝑝 < 0.001), no formal education
(𝛽 = 1.959, 𝑝 = 0.01), age (𝛽 = 0.036, 𝑝 = 0.016), illness
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Table 1: Sociodemographic characteristics of respondents by gen-
der.
Characteristics Gender Total (%) 𝑝 value
Male (%) Female (%)
Age group (in years)
20–30 3 (0.8) 2 (0.5) 5 (1.3)
0.15
31–40 15 (4) 27 (7.1) 42 (11.1)
41–50 30 (7.9) 50 (13.2) 80 (21.1)
51–60 74 (19.5) 56 (14.8) 130 (34.3)
61–70 67 (17.7) 55 (14.5) 122 (32.2)
Family type
Nuclear 164 (43.3) 161 (42.5) 325 (85.8) 0.571
Joint 25 (6.6) 29 (7.7) 54 (14.2)
Place of residence
Urban 152 (40.1) 169 (44.6) 321 (84.7) 0.021
Rural 37 (9.8) 21 (5.5) 58 (15.3)
Ethnicity
Chhetri 29 (7.7) 32 (8.4) 61 (16.1)
0.005∗
Brahman 58 (15.3) 29 (7.7) 87 (23)
Newar 83 (21.9) 95 (25.1) 178 (47)
Janajati 13 (3.4) 25 (6.6) 38 (10)
Others 6 (1.6) 9 (2.4) 15 (4)
Religion
Hindu 175 (46.2%) 155 (40.9) 330 (87.1) 0.001∗
Others 14 (3.7) 35 (9.2) 49 (12.9)
Occupation
Job 59 (15.6) 21 (5.5) 80 (21.1)
0.00∗∗∗
Business 48 (12.7) 21 (5.5) 69 (18.2)
Farming 26 (6.9) 11 (2.9) 37 (9.8)
Homemaker 3 (0.8) 110 (29) 113 (29.8)
Jobless 20 (5.3) 10 (2.6) 30 (7.9)
Others 33 (8.7) 17 (4.5) 50 (13.2)
Education level
No formal
education 9 (2.4) 75 (19.8) 84 (22.2)
0.00∗∗∗
Less than primary 3 (0.8) 4 (1.1) 7 (1.8)
Primary 27 (7.1) 43 (11.3) 70 (18.5)
Secondary 49 (12.9) 32 (8.4) 81 (21.4)
Higher secondary 30 (7.9) 16 (4.2) 46 (12.1)
Bachelor’s degree 42 (11.1) 14 (3.7) 56 (14.8)
Master’s degree 29 (7.7) 6 (1.6) 35 (9.2)
Socioeconomic
status
Lower 12 (3.2) 98 (25.9) 110 (29)
0.00∗∗∗
Upper lower 97 (25.6) 73 (19.3) 170 (44.9)
Lower middle 44 (11.6) 8 (2.1) 52 (13.7)
Upper middle 36 (9.5) 11 (2.9) 47 (12.4)
Upper — —
Marital status
Married 186 (49.1) 155 (40.9) 341 (90) 0.00∗∗∗
Others 3 (0.8) 35 (9.2) 38 (10)
∗
𝑝 < 0.05, ∗∗𝑝 < 0.01, and ∗∗∗𝑝 < 0.001.
coherence (𝛽 = −0.109, 𝑝 = 0.007), mode of treatment (𝛽 =
0.9, 𝑝 = 0.047), and consequences (𝛽 = 0.093, 𝑝 = 0.049),
Table 2: Reliability test (Cronbach alpha) for illness perception and
BDI-II scale.
Scales Mean SD Cronbach alphavalue
Identity 6.6 3.7 0.738
Timeline (acute and
chronic) 21.5 3.8 0.83
Consequences 17.7 3.8 0.644
Personal control 22.7 2.4 0.5
Treatment control 16.9 2.2 0.3
Illness coherence 16.1 3.9 0.828
Timeline (cyclical) 11.7 3.4 0.785
Emotional
representation 17.9 4.9 0.839
Cause 49.7 7.5 0.726
Depression (BDI-II)
scale 12.9 8.1 0.869
were finalized as significant predictors of depressive symp-
toms (Table 5). Multivariable analysis showed that one-year
increase in age shifted odds of having depressive symptoms
by 1.037. People without formal education had seven times
higher chance of suffering from depressive symptoms than
people with Master’s degree. In the same way, treatment
with insulin had higher likelihood of getting depressive
symptoms than the people taking oral medication. People
using insulin for treatment of their diabetes had tendency
to suffer from depressive symptoms 2.3 times higher than
people on medication. Likewise, illness perception related to
identity, consequences, and emotional representation about
diabetes had positive relationship with depressive symptoms.
One-unit increase in identity, consequences, and emotional
representation heightened the likelihood of getting depres-
sive symptoms among diabetes patients by 21%, 9.8%, and
23.9%, respectively. On the other hand, the same amount
increase in illness coherencewas responsible for 10%decrease
in depressive symptoms among diabetes patients.
4. Discussion
The current study found prevalence of depressive symptoms
in diabetic patients to be 44.1%. This result was in line with
the study conducted in Nepal in similar setting where the
prevalence was seen to be 40.3% [14]. This rate was also
comparable to prevalence of depression (36.6%) as reported
in a meta-analysis of studies among persons with diabetes in
clinical settings [32].
4.1. Depressive Symptoms in relation to Sociodemographic Fac-
tors. Our study showed that female respondents with lower
socioeconomic status and lower educational background and
homemakers were significantly associated with depressive
symptoms. Various studies have reported that female, elderly
people and single women are more susceptible to anxiety and
depression [33–37]. Ameta-analysis including 39 studies also
demonstrated that the prevalence of depression in patients
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Table 3: Distribution of depressive symptoms by sociodemographic
characteristics and behavior factors.
Characteristics Depressive symptoms Total 𝑝 value
No (%) Yes (%)
Age group
20–30 2 (0.5) 3 (0.8) 5 (1.3)
0.001∗∗
31–40 27 (7.1) 15 (4) 42 (11.1)
41–50 45 (11.9) 35 (9.2) 80 (21.1)
51–60 87 (23) 43 (11.3) 130 (34.3)
61–70 51 (13.5) 71 (18.7) 122 (32.2)
Sex
Male 131 (34.6) 58 (15.3) 189 (49.9) 0.000∗∗∗
Female 81 (21.4) 109 (28.8) 190 (50.1)
Family type
Nuclear 187 (49.3) 138 (36.4) 325 (85.8) 0.123
Joint 25 (6.6) 29 (7.7) 54 (14.2)
Place of residence
Urban 181 (47.8) 140 (36.9) 321 (84.7) 0.678
Rural 31 (8.2) 27 (7.1) 58 (15.3)
Ethnicity
Chhetri 37 (9.8) 24 (6.3) 61 (16.1)
0.347
Brahman 47 (12.4) 40 (10.6) 87 (23)
Newar 102 (26.9) 76 (20.1) 178 (47)
Janajati 16 (4.2) 22 (5.8) 38 (10)
Others 10 (2.6) 5 (1.3) 15 (4)
Religion
Hindu 185 (48.8) 145 (38.3) 330 (87.1) 0.9
Others 27 (7.1) 22 (5.8) 49 (12.9)
Occupation
Job 58 (15.3) 22 (5.8) 80 (21.1)
0.000∗∗∗
Business 49 (12.9) 20 (5.3) 69 (18.2)
Farming 19 (5) 18 (4.7) 37 (9.8)
Homemaker 39 (10.3) 74 (19.5) 113 (29.8)
Jobless 16 (4.2) 14 (3.7) 30 (7.9)
Others 31 (8.2) 19 (5) 50 (13.2)
Education level
No formal
education 18 (4.7) 66 (17.4) 84 (22.2)
0.000∗∗∗
Less than primary 4 (1.1) 3 (0.8) 7 (1.8)
Primary 32 (8.4) 38 (10) 70 (18.5)
Secondary 55 (14.5) 26 (6.9) 81 (21.4)
Higher secondary 32 (8.4) 14 (3.7) 46 (12.1)
Bachelor’s degree 45 (11.9) 11 (2.9) 56 (14.8)
Master’s degree 26 (6.9) 9 (2.4) 35 (9.2)
Socioeconomic status
Lower 32 (8.2) 78 (20.6) 110 (29)
0.000∗∗∗Upper lower 98 (25.9) 72 (19) 170 (44.9)
Lower middle 45 (11.9) 7 (1.8) 52 (13.7)
Upper middle 37 (9.8) 10 (2.6) 47 (12.4)
Table 3: Continued.
Characteristics Depressive symptoms Total 𝑝 value
No (%) Yes (%)
Marital status
Married 198 (52.2) 143 (37.7) 341 (90) 0.012∗
Others 14 (3.7) 24 (6.3) 38 (10)
Alcohol consumption
Yes 31 (8.2) 14 (3.7) 45 (11.9) 0.062
No 181 (47.8) 153 (40.4) 334 (88.1)
Smoking
Yes 25 (6.6) 11 (2.9) 36 (9.5) 0.86
No 187 (49.3) 156 (41.2) 343 (90.5)
Mode of treatment
Insulin 21 (5.5) 37 (9.8) 58 (15.3) 0.001∗∗
Oral medication 191 (50.4) 130 (34.3) 321 (84.7)
∗
𝑝 < 0.05, ∗∗𝑝 < 0.01, and ∗∗∗𝑝 < 0.001.
with diabetes was significantly high in women compared to
men [10]. Similarly, a study conducted in hospital settings
in India pointed out that depression was more prevalent in
female as compared to males [38]. The high proportion of
depressive symptoms in women might have been observed
because of the presence of more females from low socioeco-
nomic group, having less educational status, and spending
most time as homemaker compared to men. Besides, low
socioeconomic status, having less education, and spending
most time as homemaker have their association with depres-
sion among diabetic patients independently [34, 36, 37]. This
study clearly indicated that depressive symptoms did not have
a significant disproportional distribution among different
religions, family type, and ethnic groups. In the same way,
this study also did not find a significant association of alcohol
consumption and smoking with depressive symptoms, which
is consistent with previous studies conducted in similar
setting in Kathmandu, Nepal, and Tlemcen, Algeria [14, 39].
Similarly, presence of depressive symptoms was signifi-
cantly high among the people who were using insulin for the
treatment of diabetes compared to the participants using only
medications. They might have perceived insulin treatment
as the severity of condition as well as the burden to their
daily activities. Katon et al. and Al-Amer et al. concluded that
taking insulin for controlling diabetes had significant associ-
ation with depression [34, 40]. Our study also could not show
a significant relationship between depressive symptoms and
duration of diabetes. This was consistent with other studies
that reported no significant relationship of the duration of
diabetes with depression [40–42].
4.2. Depressive Symptoms and Illness Perception. Our study
demonstrated that illness perception of diabetic respon-
dents was related to depressive symptoms they had. All
the components of illness perception except personal con-
trol had significant relationship with depressive symptoms.
This suggested participants with high depressive symptoms
perceived diabetes as a condition having more symptoms.
6 Journal of Diabetes Research




















∗∗ 0.328∗∗ 0.35 1
Consequences 0.511∗∗ 0.410∗∗ 0.170∗∗ 0.437∗∗ 1
Personal










−0.305∗∗ −0.018 −0.515∗∗ −0.356∗∗ 0.193∗∗ 0.166∗∗ 1
Emotional
representation 0.636
∗∗ 0.412∗∗ 0.018 0.477∗∗ 0.518∗∗ −101∗ −0.156∗∗ −0.468∗∗ 1
Cause 0.366∗∗ 0.390∗∗ 0.006 0.162∗∗ 0.395∗∗ −0.081 −0.069 −0.252∗∗ 0.342∗∗ 1
∗
𝑝 < 0.05, ∗∗𝑝 < 0.01, and ∗∗∗𝑝 < 0.001.
Table 5: Multivariable analysis of depressive symptoms (binomial logistic regression, stepwise method).
Variables Category 𝐵 𝑝 value Exp(𝐵)
Constant −8.223 0.000∗∗∗ 0.000
Age in years 0.036 0.016 1.036
Education level
Master’s degree and higher Reference 0.003∗∗
No formal education 1.959 0.001∗∗ 7.095
Less than primary 0.131 0.902 1.140
Primary 0.651 0.257 1.917
Secondary 0.052 0.928 1.053
Higher secondary 0.578 0.366 1.782
Bachelor’s degree 0.183 0.783 1.201
Mode of treatment Medicine Reference
Insulin 0.900 0.047∗ 2.307
Identity 0.196 0.000∗∗∗ 1.216
Consequences 0.093 0.049∗ 1.098
Illness coherence −0.109 0.007∗∗ 0.896
Emotional representation 0.214 0.000∗∗∗ 1.239
∗
𝑝 < 0.05, ∗∗𝑝 < 0.01, and ∗∗∗𝑝 < 0.001.
They also believed that their illnesswasmore severe and cycli-
cal in nature, had less effective treatment control, possessed
more serious consequences, was less understandable, and
consisted of many causal factors. In comparison to respon-
dents having no depressive symptoms, they also expressed
high emotional response. These findings were consistent
with another study conducted among patients having end
stage of renal disease that reported a significant corelation
of identity, cyclical nature, consequences, personal control,
treatment control, illness coherence, emotional response, and
causes with depression [16]. Also, in researches conducted in
rheumatoid arthritis and cardiac patients, perceiving serious
illness consequences had negatively been correlated with
depression [22, 43]. Our study could not substantiate the
same study that reported personal control had a significant
relation with depressive symptoms [22]. In our study, we
found the majority of the participants believed they could
control their symptoms. Irrespective of presence of strong
confidence over the personal control of diabetes among the
participants, the reason behind not having its significant
relationship with depressive symptoms remained unclear.
This study also identified the illness identity, conse-
quences, emotional representations, and coherence as the
significant predictors of depressive symptoms. Patients who
perceived more symptoms (identity), more consequences,
high emotional response, and less understanding (coherence)
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of diabetes were likely to have more depressive symptoms
than others. Findings were suggestive of the fact that patients
were more likely to get depressed when they knew less
about their condition. Similarly, patients with high depressive
symptoms were likely to experience many symptoms of
diabetes that were, in fact, not related to it. According to
Leventhal’s model of self-regulation, patients make their own
lay views about disease after experiencing the symptoms and
that cognition shapes their coping behaviors [17, 18, 44].
Therefore, familiarity with the symptoms and complications
of any disease can make the patient more confident to deal
with it [45], whereas poor perception leads to maladaptive
outcomes of psychological distress [44, 46].
Overall, the current study identified a relationship
between illness perception and depressive symptoms among
diabetic patients. This study is the first to establish their
relationship among persons with diabetes in Nepal. It has
major implication for the development of patient centered
intervention in prevention and management of depressive
symptoms among Nepalese diabetic patients. Addressing
illness perception early on persons with diabetes can provide
the opportunity to improve their beliefs and can achieve
significant positive influences on disease outcomes [45, 47].
However, it was only an analytical cross- sectional study.
This negates the ability to decide the causality. It does not
uncover the relationship of illness perception and glycemic
control in diabetic patients. As many studies reported the
significant association of glycemic control with depression
[48], understanding the tripartite relationship of illness per-
ception, glycemic control, and depression among diabetic
patients could be an interesting area of study in future.
Similarly, the poor internal consistency of treatment control
and personal control IPQ-R subscales is also concerning
limitation of the study. But inadequate reliability coefficient
of aforementioned two subscales seems to be a generalized
problem. Several studies reported the same [49–51]. Lastly,
samples were taken from clinical settings and could not
represent community as a whole; a community based study
is warranted for better representation.
5. Conclusion
This study underlines the importance of understanding of
illness perception for preventing depressive symptoms that
paves the way for effective treatment and control among type
2 diabetics. Providing information about the cause, pathol-
ogy, complication, and overall treatment of disease can help
to form a decent illness perception. Hospital and treatment
centers should create a favorable environment where patients
can have access to authentic and appropriate information
and check the viability of their illness perceptions. This may
help patients to follow active coping behaviors, ultimately
preventing depressive symptoms and also helping in the
treatment and control of diabetes.
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